Cerebral vasoreactivity to acetazolamide is not impaired in patients with severe sepsis

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 337-343

  Fülesdi, Béla ^a   Szatmári, Szilárd ^a   Antek, Csaba ^a   Fülep, Zoltán ^a   Sárkány, Péter ^a   Csiba, László ^a   Molnár, Csilla ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Acetazolamide; Cerebral vasoreactivity; Septic encephalopathy

Indexed keywords

ACETAZOLAMIDE;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN DISEASE; CEREBRAL VASOMOTOR REACTIVITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; SEPSIS; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ACETAZOLAMIDE; ADULT; AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BRAIN DISEASES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASODILATOR AGENTS;

EID: 84864149820     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.11.002     Document Type: Article

References (27)

1. Ebersoldt M., Sharshar T., Annane D. Sepsis-associated delirium. Intensive Care Med 2007, 33:941-950.
2. Iacobone E., Bailly-Salin J., Polito A., Friedman D., Stevens R.D., Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009, 37(10 Suppl):S331-336.
3. Pytel P., Alexander J.J. Pathogenesis of septic encephalopathy. Curr Opin Neurol 2009, 22:283-287.
4. Burkhart C.S., Siegemund M., Steiner L.A. Cerebral perfusion in sepsis. Crit Care 2010, 14:215.
5. Matta B.F., Stow P.J. Sepsis-induced vasoparalysis does not involve the cerebral vasculature: indirect evidence from autoregulation and carbon dioxide reactivity studies. Br J Anaesth 1996, 76:790-794.
6. Terborg C., Schummer W., Albrecht M., Reinhart K., Weiller C., Röther J. Dysfunction of vasomotor reactivity in severe sepsis and septic shock. Intensive Care Med 2001, 27:1231-1234.
7. Szatmári S., Végh T., Csomós A., Hallay J., Takács I., Molnár C., et al. Impaired cerebrovascular reactivity in sepsis-associated encephalopathy studied by acetazolamide test. Crit Care 2010, 14:R50.
8. Committee: TASCC Definitions for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis. Chest 1992, 101:1644-1655.
9. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
10. Thees C., Kaiser M., Scholz M., Semmler A., Heneka M.T., Baumgarten G., et al. Cerebral haemodynamics and carbon dioxide reactivity during sepsis syndrome. Crit Care 2007, 11:R123.
11. Bowton D.L., Bertels N.H., Prough D.S., Stump D.A. Cerebral blood flow is reduced in patients with sepsis syndrome. Crit Care Med 1989, 17:399-403.
12. Bowie R.A., O'Connor P.J., Mahajan R.P. Cerebrovascular reactivity to carbon dioxide in sepsis syndrome. Anaesthesia 2003, 58:261-265.
13. Smith S.M., Padayachee S., Modaresi K.B., Smithies M.N., Bihari D.J. Cerebral blood flow is proportional to cardiac index in patients with septic shock. J Crit Care 1998, 13:104-109.
14. Pfister D., Siegemund M., Dell-Kuster S., Smielewski P., Rüegg S., Strebel S.P., et al. Cerebral perfusion in sepsis-associated delirium. Crit Care 2008, 12:R63.
15. Taccone F.S., Zapatero D.C., Peres-Bota D., Vincent J.L., Berre J., Melot C. Cerebral autoregulation is influenced by carbon dioxide levels in patients with septic shock. Neurocrit Care 2010, 12:35-42.
16. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. Early Goal-Directed Therapy Collaborative Group.
17. Singer M., De Santis V., Vitale D., Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004, 364:545-548.
18. Trzeciak S., Dellinger R.P., Parrillo J.E., Guglielmi M., Bajaj J., Abate N.L., et al. Microcirculatory Alterations in Resuscitation and Shock Investigators. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007, 49:88-98.
19. Balestra G.M., Legrand M., Ince C. Microcirculation and mitochondria in sepsis: getting out of breath. Curr Opin Anaesthesiol 2009, 22:184-190.
20. Sharshar T., Polito A., Checinski A., Stevens R.D. Septic-associated encephalopathy-everything starts at a microlevel. Crit Care 2010, 14:199.
21. Szabó C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 1996, 41:131-141.
22. Settakis G., Molnár C., Kerényi L., Kollár J., Legemate D., Csiba L., et al. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol 2003, 10:609-620.
23. Aamand R., Dalsgaard T., Jensen F.B., Simonsen U., Roepstorff A., Fago A. Generation of nitric oxide from nitrite by carbonic anhydrase: a possible link between metabolic activity and vasodilation. Am J Physiol Heart Circ Physiol 2009, 297:H2068-H2074.
24. Murkin J.M. Cerebral autoregulation: the role of CO2 in metabolic homeostasis. Semin Cardiothorac Vasc Anesth 2007, 11:269-273.
25. Semmler A., Hermann S., Mormann F., Weberpals M., Paxian S.A., Okulla T., et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation 2008, 5:38.
26. Dahl A., Russell D., Rootwelt K., Nyberg-Hansen R., Kerty E. Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements. Dose, serum concentration, and time course of the response to acetazolamide. Stroke 1995, 26:2302-2306.
27. Schreiber S.J., Gottschalk S., Weih M., Villringer A., Valdueza J.M. Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. AJNR Am J Neuroradiol 2000, 21:1207-1211.